Management of Heart Failure Patient with CKD.
Banerjee D, Rosano G, Herzog CA.
Clin J Am Soc Nephrol. 2021 Jul;16(7):1131-1139. doi: 10.2215/CJN.14180920. Epub 2021 Jan 25.
ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing.
Russo AM, Desai MY, Do MM, Butler J, Chung MK, Epstein AE, Guglin ME, Levy WC, Piccini JP, Bhave NM, Russo AM, Desai MY, Do MM, Ambardekar AV, Berg NC, Bilchick KC, Dec GW Jr, Gopinathannair R, Han JK, Klein L, Lampert RJ, Panjrath GS, Reeves RR, Yoerger Sanborn DM, Stevenson LW, Truong QA, Varosy PD, Villines TC, Volgman AS, Zareba KM.
J Am Coll Cardiol. 2025 Mar 25;85(11):1213-1285. doi: 10.1016/j.jacc.2024.11.023. Epub 2025 Jan 13.
One-Year Mortality in Patients Undergoing an Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy Pulse Generator Replacement: Identifying Patients at Risk.
Feijen M, Egorova AD, Kuijken T, Bootsma M, Schalij MJ, van Erven L.
J Clin Med. 2023 Aug 30;12(17):5654. doi: 10.3390/jcm12175654.
Cardiac resynchronization therapy (CRT) device replacement considerations: upgrade or downgrade? A complex decision in the current clinical setting.
Nakou ES, Simantirakis EN, Kallergis EM, Nakos KS, Vardas PE.
Europace. 2017 May 1;19(5):705-711. doi: 10.1093/europace/euw317.
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.
Stiles MK, Fauchier L, Morillo CA, Wilkoff BL; ESC Scientific Document Group.
Europace. 2019 Sep 1;21(9):1442-1443. doi: 10.1093/europace/euz065.
Comparison of left ventricular lead upgrade vs continued medical care among patients eligible for cardiac resynchronization therapy at the time of defibrillator generator replacement: Predictors of left ventricular lead upgrade and associations with long-term outcomes.
Hyman MC, Bao H, Curtis JP, Minges K, Schaller RD, Birgersdotter-Green U, Marchlinski FE, Hsu JC.
Heart Rhythm. 2020 Nov;17(11):1878-1886. doi: 10.1016/j.hrthm.2020.05.032. Epub 2020 Jun 1.
Predictors and outcomes of cardiac resynchronization therapy extended to the second generator.
Li X, Yang D, Kusumoto F, Shen WK, Mulpuru S, Zhou S, Liang J, Wu G, Yang M, Liu JQ, Friedman PA, Cha YM.
Heart Rhythm. 2017 Dec;14(12):1793-1800. doi: 10.1016/j.hrthm.2017.09.002. Epub 2017 Sep 14.
Reply to the editor- The cost of cardiac resynchronization therapy generator replacement?
Li X, Friedman PA, Cha YM.
Heart Rhythm. 2018 Mar;15(3):e36. doi: 10.1016/j.hrthm.2017.12.009. Epub 2017 Dec 8.
To the Editor- The cost of cardiac resynchronization therapy generator replacement?
Claridge S, Sieniewicz B, Gould J, Rinaldi CA.
Heart Rhythm. 2018 Mar;15(3):e35-e36. doi: 10.1016/j.hrthm.2017.12.008. Epub 2017 Dec 8.
Effect of fibrotic capsule debridement during generator replacement on cardiac implantable electronic device infection risk.
Goldenberg GR, Barsheshet A, Bishara J, Kadmon E, Omelchencko A, Strasberg B, Golovchiner G.
J Interv Card Electrophysiol. 2020 Jun;58(1):113-118. doi: 10.1007/s10840-019-00581-4. Epub 2019 Jun 21.
